Signify N.V. (PHPPY)
OTCMKTS · Delayed Price · Currency is USD
12.23
-1.10 (-8.25%)
Jul 31, 2025, 12:24 PM EDT

CTI BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
2,9582,8194,2334,1995,7895,345
Upgrade
Market Cap Growth
5.94%-33.41%0.80%-27.46%8.32%35.76%
Upgrade
Enterprise Value
4,4504,0625,8736,1657,5427,463
Upgrade
Last Close Price
12.2310.6915.0014.6218.6917.00
Upgrade
PE Ratio
7.348.3018.867.5112.8213.44
Upgrade
PS Ratio
0.420.440.570.520.740.67
Upgrade
PB Ratio
0.930.831.301.281.961.88
Upgrade
P/FCF Ratio
6.045.885.9412.848.215.30
Upgrade
P/OCF Ratio
5.305.305.5010.457.234.90
Upgrade
EV/Sales Ratio
0.640.640.790.770.970.94
Upgrade
EV/EBITDA Ratio
5.566.057.156.857.557.64
Upgrade
EV/EBIT Ratio
7.727.749.169.1710.0210.74
Upgrade
EV/FCF Ratio
9.098.478.2418.8510.707.41
Upgrade
Debt / Equity Ratio
0.590.480.760.660.770.99
Upgrade
Debt / EBITDA Ratio
2.302.172.762.242.132.66
Upgrade
Debt / FCF Ratio
3.823.353.466.643.242.80
Upgrade
Asset Turnover
0.860.790.820.910.860.90
Upgrade
Inventory Turnover
3.473.493.363.403.624.49
Upgrade
Quick Ratio
0.630.720.740.780.730.98
Upgrade
Current Ratio
1.171.221.141.431.321.49
Upgrade
Return on Equity (ROE)
12.37%10.75%7.15%18.79%16.51%14.39%
Upgrade
Return on Assets (ROA)
4.42%4.09%4.45%4.75%5.18%4.92%
Upgrade
Return on Capital (ROIC)
6.95%6.34%7.06%8.10%8.96%8.44%
Upgrade
Return on Capital Employed (ROCE)
11.10%10.00%11.70%10.60%12.20%10.40%
Upgrade
Earnings Yield
13.62%12.05%5.30%13.31%7.80%7.44%
Upgrade
FCF Yield
16.56%17.01%16.84%7.79%12.18%18.86%
Upgrade
Dividend Yield
5.74%15.11%11.42%10.96%8.82%10.08%
Upgrade
Payout Ratio
66.76%60.06%93.10%35.56%89.17%5.23%
Upgrade
Buyback Yield / Dilution
0.72%-0.15%0.20%0.81%0.81%-1.62%
Upgrade
Total Shareholder Return
6.46%14.96%11.62%11.78%9.63%8.46%
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.